Special Issue "Neonatal Morbidity: Current Advances, New Perspectives and Future Challenges"

A special issue of Children (ISSN 2227-9067). This special issue belongs to the section "Pediatric Neonatology".

Deadline for manuscript submissions: 15 January 2024 | Viewed by 2782

Special Issue Editors

Department of Midwifery, School of Health and Care Sciences, University of West Attica, Athens, Greece
Interests: midwifery care; high-risk intrapartum care; intrapartum-related complications; emergencies in the perinatal period; special populations

E-Mail Website
Guest Editor Assistant
Department of Midwifery, University of West Attica, 12243 Athens, Greece
Interests: midwifery care; perinatal care; neonatal care; infectious diseases; neonatal intensive care; critically-ill neonates; neonatal brain injury; biomarkers

Special Issue Information

Dear Colleagues,

Although significant advances have been achieved in perinatology and intensive neonatal care, rates of neonatal morbidity and adverse sequelae remain high, underlining the need for interdisciplinary cooperation to improve neonatal health outcomes. Scientific fields and technologies related to the measurement of biological molecules are rapidly evolving, and offer ever-expanding information for a comprehensive understanding of the neonatal biological system, thus contributing to the early identification of neonates at high risk of developing complications and life-threatening diseases. This knowledge could assist clinicians and neonatal intensive care unit (NICU) staff to plan individualized interventions which will either prevent or optimize neonatal outcomes.

Systematic antenatal care, the diagnosis and treatment of maternal infections, the detection of perinatal risk factors and focused neonatal care are key aspects of both reducing neonatal morbidity and improving neonatal prognosis. Intrapartum- and prematurity-related complications are closely related to neonatal morbidity, highlighting the necessity of skilled obstetricians and midwives, evidence-based and up-to-date guidelines, effective prevention methods and high-quality healthcare facilities. A number of protective actions are now at the center of early intervention programs in the NICU, and their goal is to sustain preterm neonates’ development by empowering their potentialities. It is now evident that the environment and the sensory stimuli, predominantly during the perinatal period, have an impact on neonate development. Parents do not simply facilitate environmental stimuli, but are part of the environment itself, changing their interaction according to the neonate’s needs, reactions, and requests and impacting on its socio-emotional development. Lastly, an imperative goal for healthcare professionals to consider is the reduction of the economic, social and, above all, family burden resulting from neonatal morbidity. 

This Special Issue of Children is an update on current advances pertaining to the prevention, prevalence, risk factors, diagnosis, etiology, pathophysiology, treatment, as well as short- and long-term neurodevelopmental outcomes of several neonatal critical conditions. We also encourage submissions that investigate and demonstrate new perspectives and discuss future challenges regarding neonatal morbidity. Finally, this Special Issue aims to highlight the pivotal role of the interdisciplinary team in the neonatal period, raise awareness of novel biomarkers and effective pharmacological and non-pharmacological therapies, and enhance the understanding of family dynamics in special populations such as high-risk and critically-ill neonates. We invite researchers and colleagues to submit original research articles, reviews and case reports that address relevant topics.

We wish for a pleasant collaboration and look forward to receiving your contributions.

Prof. Dr. Katerina Lykeridou
Guest Editor

Dr. Dimitra Metallinou
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Other

Article
Serum YKL-40 as a Potential Biomarker for Sepsis in Term Neonates—A Pilot Study
Children 2023, 10(5), 772; https://doi.org/10.3390/children10050772 - 25 Apr 2023
Viewed by 759
Abstract
Although YKL-40 is a promising diagnostic biomarker of sepsis in adults, its value in neonatal sepsis is not known. The study objectives included assessing the levels and diagnostic value of serum YKL-40 in term neonates with sepsis and comparing YKL-40 with other commonly [...] Read more.
Although YKL-40 is a promising diagnostic biomarker of sepsis in adults, its value in neonatal sepsis is not known. The study objectives included assessing the levels and diagnostic value of serum YKL-40 in term neonates with sepsis and comparing YKL-40 with other commonly used inflammatory biomarkers. In this pilot case–control study, 45 term neonates (30 septic and 15 non-septic, as controls), 4 to 28 days old, were prospectively studied. The International Pediatric Sepsis Consensus Conference criteria were applied to diagnose sepsis. During the acute phase (admission) and remission of sepsis, blood samples were collected from cases (while from controls they were only collected once) for routine laboratory tests, cultures, and the measurement of serum YKL-40 levels via Elisa. In the acute phase of sepsis, YKL-40 levels were significantly elevated in comparison with remission (p = 0.004) and controls (p = 0.003). YKL-40 levels did not differ significantly between patients in remission and controls (p = 0.431). Upon admission, YKL-40 levels correlated positively with white blood count, absolute neutrophil count, and CRP levels. Via ROC analysis, it was shown that YKL-40 levels upon admission were a significant indicator of sepsis (AUC = 0.771; 95% CI 0.632–0.911; p = 0.003). Serum YKL-40 might be considered as an adjuvant biomarker of sepsis in term neonates. Full article
Show Figures

Figure 1

Article
The Molecular and Histopathological Assessment of Inflammatory Status in Very and Extremely Premature Infants: A Prospective Study
Children 2023, 10(2), 352; https://doi.org/10.3390/children10020352 - 10 Feb 2023
Cited by 1 | Viewed by 809
Abstract
Prematurity comes with a varying range of complications, implying a high prevalence of complications and mortality and depending on the severity of prematurity and the sustained inflammation among these infants, which recently sparked an important scientific interest. The primary objective of this prospective [...] Read more.
Prematurity comes with a varying range of complications, implying a high prevalence of complications and mortality and depending on the severity of prematurity and the sustained inflammation among these infants, which recently sparked an important scientific interest. The primary objective of this prospective study was to establish the degree of inflammation in very (VPIs) and extremely preterm infants (EPIs) in association with the histology findings of the umbilical cord (UC), while the secondary objective was to study the inflammatory markers in the neonates’ blood as predictors of fetal inflammatory response (FIR). A total of thirty neonates were analyzed, ten of them being born extremely premature (<28 weeks of gestation) and twenty very premature (28–32 weeks of gestation). The EPIs had considerably higher levels of IL-6 at birth than VPIs (638.2 pg/mL vs. 151.1 pg/mL). The CRP levels at delivery did not vary substantially across groups; however, after days, the EPIs had significantly higher CRP levels (11.0 mg/dL vs. 7.2 mg/dL). In contrast, the LDH was considerably higher in the extremely preterm infants at birth and four days after birth. Surprisingly, the proportions of infants with pathologically increased inflammatory markers did not differ between the EPIs and VPIs. The LDH increased considerably in both groups, although the CRP levels increased exclusively among the VPIs. The stage of inflammation in the UC did not vary substantially between the EPIs and VPIs. The majority of infants were identified with Stage 0 UC inflammation (40% in EPI vs. 55% in VPIs). There was a substantial correlation link between gestational age and newborn weight and a significant inverse correlation among gestational age and IL-6 and LDH levels. There was a strong negative association between weight and IL-6 (rho = −0.349) and LDH (rho = −0.261). The stage of the UC inflammation demonstrated a statistically significant direct connection with IL-6 (rho = 0.461) and LDH (rho = 0.293), but none with the CRP. Further studies involving a bigger population size of preterm newborns are required to validate the findings and analyze more inflammatory markers, while prediction models on inflammatory markers that are measured expectantly, before the onset of preterm labor, need to be created. Full article
Show Figures

Figure 1

Other

Jump to: Research

Case Report
Autosomal Dominant Hypocalcemia Type 1 and Neonatal Focal Seizures
Children 2023, 10(6), 1011; https://doi.org/10.3390/children10061011 - 03 Jun 2023
Viewed by 782
Abstract
Autosomal dominant hypocalcemia type 1 (ADH1) is a rare form of hypoparathyroidism that is characterized by gain-of-function mutations in the CASR gene, which provides instructions for producing the protein called calcium-sensing receptor (CaSR). Hypocalcemia in the neonatal period has a wide differential diagnosis. [...] Read more.
Autosomal dominant hypocalcemia type 1 (ADH1) is a rare form of hypoparathyroidism that is characterized by gain-of-function mutations in the CASR gene, which provides instructions for producing the protein called calcium-sensing receptor (CaSR). Hypocalcemia in the neonatal period has a wide differential diagnosis. We present the case of a female newborn with genetic hypoparathyroidism (L125P mutation of CASR gene), hypocalcemia, and neonatal seizures due to the potential correlation between refractory neonatal seizures and ADH1. Neonatal seizures were previously described in patients with ADH1 but not in association with the L125P mutation of the CASR gene. Prompt diagnosis and management by a multidisciplinary and an appropriate therapeutic approach can prevent neurological and renal complications. Full article
Show Figures

Figure 1

Back to TopTop